A team of life science entrepreneurs in Houston, Texas has developed the first catheter-deployed circulatory assist device intended for long-term use in the treatment of chronic heart failure. Procyrion, Inc.’s Aortix™ provides a minimally invasive treatment option for the more than two million chronic heart failure patients who are too sick for medication. This pre-clinical cardiologist tool dramatically reduces risks associated with circulatory support devices and enables treatment of younger, healthier patients before progressive damage occurs.